COVID-19 IN PATIENTS WITH MYELOPROLIFERATIVE NEOPLASMS: THE RISK OF THROMBOEMBOLIC EVENTS AND CURRENT OPTIONS FOR ANTITHROMBOTIC PROPHYLAXIS

COVID-19 IN PATIENTS WITH MYELOPROLIFERATIVE NEOPLASMS: THE RISK OF THROMBOEMBOLIC EVENTS AND CURRENT OPTIONS FOR ANTITHROMBOTIC PROPHYLAXIS

Aim: to provide a literature review of the presently available data on the risk of thromboembolic events and current options for antithrombotic prophylaxis in patients with myeloproliferative neoplasms (MPN) patients with concomitant coronavirus disease 2019 (COVID-19). Material and methods. The...

Full description

Bibliographic Details
Main Authors: O.M. Kostiukevych, L.K. Benkovska, A.M. Kravchenko, T.Ya. Chursina, K.O. Mikhaliev
Format: Article
Language:English
Published: State Institution of Science «Research and Practical Center of Preventive and Clinical Medicine» State Administrative Department 2022-10-01
Series:Клінічна та профілактична медицина
Subjects:
sars-cov-2 infection
coronavirus disease 2019 (covid-19)
myeloproliferative neoplasms
thrombosis
antithrombotic prophylaxis
antithrombotic therapy
Online Access:https://cp-medical.com/index.php/journal/article/view/236

Internet

https://cp-medical.com/index.php/journal/article/view/236

Similar Items